Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-07-18
2006-07-18
O'Hara, Eileen B. (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S389100, C514S002600, C514S008100, C514S012200, C435S007100, C436S501000
Reexamination Certificate
active
07078494
ABSTRACT:
Polynucleotides encoding the IL-13 receptor and fragments thereof are disclosed. IL-13 receptor proteins, methods for their production, inhibitors of binding of IL-13 and its receptor and methods for their identification are also disclosed.
REFERENCES:
patent: 5011912 (1991-04-01), Hopp et al.
patent: 5599905 (1997-02-01), Mosley et al.
patent: 5696234 (1997-12-01), Zurawski et al.
patent: 2003/0100046 (2003-05-01), Baumgartner et al.
patent: 2003/0100047 (2003-05-01), Baumgartner et al.
patent: 0876482 (1996-07-01), None
patent: WO 94/04680 (1994-03-01), None
patent: WO 97/15663 (1997-05-01), None
patent: WO 97/20926 (1997-06-01), None
patent: WO 97/33913 (1997-09-01), None
Sugamura, et al. Geneseq28database Acc.No. R82934.
Mijares et al. Molecular Pharmacology, vol. 58, pp. 373-379, 2000.
Caput et al., The Journal of Biological Chemistry 271(28):16921-16926 (1996).
Vita et al., The Journal of Biological Chemistry 270(8):3512-3517 (1995).
Obiri et al., The Journal of Biological Chemistry 270(15):8797-8804 (1995).
Zurawski et al., The Journal of Biological Chemistry 270(23):13869-13878 (1995).
Husain, et al., “Interleukin-13 Receptor as a Unique Target for Anti-Glioblastoma Therapy”,Int. J. Cancer,vol. 92 (2001), pp. 168-175.
Barth, “hIL-13 PE38QQR NeoPharm”,Current Opinion in Investigational Drugs,vol. 2, No. 9 (2001), pp. 1309-1313.
Li, et al., “Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion proteinin vitroandin vivoin nude mice”,Protein Engineering,vol. 15, No. 5 (2002), pp. 419-427.
Husain, et al., “Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside”,Journal of Neuro-Oncology,vol. 65 (2003), pp. 37-48.
Mintz, et al., “Molecular targeting with recombinant cytotoxins of interleukin-13 receptor α2-expressing glioma”,Journal of Neuro-Oncology,vol. 64 (2003), pp. 117-123.
Collins Mary
Donaldson Debra
Fitz Lori
Neben Tamlyn
Whitters Matthew
Genetics Institute LLC
Hamud Fozia
O'Hara Eileen B.
LandOfFree
Antibodies to human IL-13bc and methods of their use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to human IL-13bc and methods of their use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to human IL-13bc and methods of their use in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3582687